Mara Rubino
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Mara Rubino has a total of 85 co-authors. Here are the top co-authors by number of shared publications:
- Giancarlo Marenzi
Centro Cardiologico Monzino, IRCCS, 20138 Milan, Italy
19 shared publications - Monica De Metrio
Centro Cardiologico Monzino, I.R.C.C.S., 20138 Milan, Italy
15 shared publications Marco Moltrasio
Centro Cardiologico Monzino, I.R.C.C.S, Milan, Italy bDivision of Nutritional Epidemiology, Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden
14 shared publicationsFabrizio Veglia
11 shared publicationsIvana Marana
11 shared publicationsGianfranco Lauri
10 shared publications
Latest Publications
- Open Access
- 18 May 2023
- Published by Oxford University Press (OUP) in European Heart Journal Supplements
- Vol. 25 (Supplement) , D176
P335 TEMPORAL TRENDS (2003–2018) OF IN–HOSPITAL AND 30–DAY MORTALITY IN PATIENTS HOSPITALIZED WITH ACUTE HEART FAILURE IN LOMBARDY
Limited and controversial temporal trend of in–hospital mortality of patients hospitalized with acute heart failure (AHF) have been reported. We evaluated whether, in AHF hospitalized patients, the rate of in–hospital and 30–day mortality, and 30–day re–hospitalization for AHF changed in the last 15 years. We examined administrative data from Lombardy (∼10.000.000 inhabitants), Italy. We analyzed data of all adults hospitalized for AHF from 2003 to 2018 in Lombardy. Patients were stratified according to hospitalization period: 2003–2006; 2007–2010; 2011–2014; 2015–2018. The primary study endpoint was the comparison among periods of in–hospital mortality, while secondary endpoints were 30–day mortality and re–hospitalization for AHF temporal trends. During the study period, 414,164 patients were hospitalized with a primary diagnosis of AHF. The in–hospital and 30–day mortality in the entire cohort showed a progressive increase over time (from 6.7% to 8.5% and from 12.4% to 14.5%, respectively). Thirty–day re–hospitalization for AHF was 2% showing a progressive decrease across years. However, patient’ complexity, as inferable from number of comorbidities, increased in most recently hospitalized patients. After matching for age, gender, and admission ward, the study population included 78,884 patients in each study period. In the matched population, after further adjustment for major comorbidities, the risk of in–hospital and 30–day mortality and of the 30–day risk of AHF re–hospitalization progressively decreased from one period to the following one by 1% (95% confidence interval [CI] 0%–2%), 2% (1%–3%) and 10% (8%–12%), respectively. In our study, the greater patients’ complexity largely accounted for the continuing rise in early mortality observed in patients hospitalized with AHF. This work was partly financed by the Italian Ministry of Health and the Lombardia Region (Grant NET–2016–02364191; EASY–NET).
- 18 May 2023
- Published by Oxford University Press (OUP) in European Heart Journal Supplements
- Vol. 25 (Supplement) , D176
Open AccessP335 TEMPORAL TRENDS (2003–2018) OF IN–HOSPITAL AND 30–DAY MORTALITY IN PATIENTS HOSPITALIZED WITH ACUTE HEART FAILURE IN LOMBARDY
Limited and controversial temporal trend of in–hospital mortality of patients hospitalized with acute heart failure (AHF) have been reported. We evaluated whether, in AHF hospitalized patients, the rate of in–hospital and 30–day mortality, and 30–day re–hospitalization for AHF changed in the last 15 years. We examined administrative data from Lombardy (∼10.000.000 inhabitants), Italy. We analyzed data of all adults hospitalized for AHF from 2003 to 2018 in Lombardy. Patients were stratified according to hospitalization period: 2003–2006; 2007–2010; 2011–2014; 2015–2018. The primary study endpoint was the comparison among periods of in–hospital mortality, while secondary endpoints were 30–day mortality and re–hospitalization for AHF temporal trends. During the study period, 414,164 patients were hospitalized with a primary diagnosis of AHF. The in–hospital and 30–day mortality in the entire cohort showed a progressive increase over time (from 6.7% to 8.5% and from 12.4% to 14.5%, respectively). Thirty–day re–hospitalization for AHF was 2% showing a progressive decrease across years. However, patient’ complexity, as inferable from number of comorbidities, increased in most recently hospitalized patients. After matching for age, gender, and admission ward, the study population included 78,884 patients in each study period. In the matched population, after further adjustment for major comorbidities, the risk of in–hospital and 30–day mortality and of the 30–day risk of AHF re–hospitalization progressively decreased from one period to the following one by 1% (95% confidence interval [CI] 0%–2%), 2% (1%–3%) and 10% (8%–12%), respectively. In our study, the greater patients’ complexity largely accounted for the continuing rise in early mortality observed in patients hospitalized with AHF. This work was partly financed by the Italian Ministry of Health and the Lombardia Region (Grant NET–2016–02364191; EASY–NET).
- 1 November 2016
- Published by Wolters Kluwer Health in Journal of Cardiovascular Medicine
- Vol. 17 (11) , 803-809
Brain natriuretic peptide in acute myocardial infarction
Cardiac and renal functions are major independent predictors of outcomes in both ST-segment elevation myocardial infarction (STEMI) and non-ST-segment elevation myocardial infarction (NSTEMI). As B-type natriuretic peptide (BNP) seems to be a major mediator in the cross-talk between heart and kidneys, we aimed at evaluating its capacity to reflect cardiac and renal function in patients with STEMI and NSTEMI. We measured BNP plasma levels at hospital admission in 619 patients with STEMI (n = 346) and NSTEMI (n = 273), grouped according to left ventricular ejection fraction (LVEF; > or ≤40%) and estimated glomerular filtration rate (eGFR; > or ≤ 60 ml/min/1.73 m). Median BNP values were 82 (38-186), 121 (40-342), 219 (80-685), and 474 (124-1263) pg/ml in patients with normal LVEF and eGFR (n = 347), with LVEF 40% or less and eGFR higher than 60 ml/min/1.73 m (n = 120), with LVEF higher than 40% and eGFR 60 ml/min/1.73 m or less (n = 86), and with combined LVEF and eGFR reductions (n = 66), respectively (P < 0.0001). At general linear model, both LVEF higher than 40% (P < 0.0001) and eGFR 60 ml/min/1.73 m or less (P < 0.0001) independently predicted BNP values. At multivariable analysis, BNP, LVEF 40% or less, and eGFR 60 ml/min/1.73 m or less were found to be independent predictors of the combined end point of in-hospital death, cardiogenic shock, need for renal replacement therapy, or mechanical ventilation (P = 0.003; P < 0.0001; P = 0.01, respectively). BNP plasma levels are closely related to LVEF and eGFR at hospital admission, in both STEMI and NSTEMI patients. Future studies should investigate whether BNP levels can summarize in a single parameter the prognostic information provided separately by cardiac and renal dysfunction.
- 1 November 2016
- Published by Wolters Kluwer Health in Journal of Cardiovascular Medicine
- Vol. 17 (11) , 803-809
Brain natriuretic peptide in acute myocardial infarction
Cardiac and renal functions are major independent predictors of outcomes in both ST-segment elevation myocardial infarction (STEMI) and non-ST-segment elevation myocardial infarction (NSTEMI). As B-type natriuretic peptide (BNP) seems to be a major mediator in the cross-talk between heart and kidneys, we aimed at evaluating its capacity to reflect cardiac and renal function in patients with STEMI and NSTEMI. We measured BNP plasma levels at hospital admission in 619 patients with STEMI (n = 346) and NSTEMI (n = 273), grouped according to left ventricular ejection fraction (LVEF; > or ≤40%) and estimated glomerular filtration rate (eGFR; > or ≤ 60 ml/min/1.73 m). Median BNP values were 82 (38-186), 121 (40-342), 219 (80-685), and 474 (124-1263) pg/ml in patients with normal LVEF and eGFR (n = 347), with LVEF 40% or less and eGFR higher than 60 ml/min/1.73 m (n = 120), with LVEF higher than 40% and eGFR 60 ml/min/1.73 m or less (n = 86), and with combined LVEF and eGFR reductions (n = 66), respectively (P < 0.0001). At general linear model, both LVEF higher than 40% (P < 0.0001) and eGFR 60 ml/min/1.73 m or less (P < 0.0001) independently predicted BNP values. At multivariable analysis, BNP, LVEF 40% or less, and eGFR 60 ml/min/1.73 m or less were found to be independent predictors of the combined end point of in-hospital death, cardiogenic shock, need for renal replacement therapy, or mechanical ventilation (P = 0.003; P < 0.0001; P = 0.01, respectively). BNP plasma levels are closely related to LVEF and eGFR at hospital admission, in both STEMI and NSTEMI patients. Future studies should investigate whether BNP levels can summarize in a single parameter the prognostic information provided separately by cardiac and renal dysfunction.
- 1 June 2016
- Published by Elsevier in International Journal of Cardiology
- Vol. 212, 318-323
B-type natriuretic peptide levels in patients with pericardial effusion undergoing pericardiocentesis
- 1 June 2016
- Published by Elsevier in International Journal of Cardiology
- Vol. 212, 318-323
B-type natriuretic peptide levels in patients with pericardial effusion undergoing pericardiocentesis
- 1 December 2015
- Published by Elsevier in The American Journal of Cardiology
- Vol. 116 (12) , 1791-1797
Myocardial Infarct Size in Patients on Long-Term Statin Therapy Undergoing Primary Percutaneous Coronary Intervention for ST-Elevation Myocardial Infarction
- 1 December 2015
- Published by Elsevier in The American Journal of Cardiology
- Vol. 116 (12) , 1791-1797
Myocardial Infarct Size in Patients on Long-Term Statin Therapy Undergoing Primary Percutaneous Coronary Intervention for ST-Elevation Myocardial Infarction
- Open Access
- 1 May 2015
- Published by Wolters Kluwer Health in Medicine
- Vol. 94 (19) , e857-8
Vitamin D Plasma Levels and In-Hospital and 1-Year Outcomes in Acute Coronary Syndromes
Deficiency in 25-hydroxyvitamin D (25[OH]D), the main circulating form of vitamin D in blood, could be involved in the pathogenesis of acute coronary syndromes (ACS). To date, however, the possible prognostic relevance of 25 (OH)D deficiency in ACS patients remains poorly defined. The purpose of this prospective study was to assess the association between 25 (OH)D levels, at hospital admission, with in-hospital and 1-year morbidity and mortality in an unselected cohort of ACS patients. We measured 25 (OH)D in 814 ACS patients at hospital presentation. Vitamin D serum levels >30 ng/mL were considered as normal; levels between 29 and 21 ng/mL were classified as insufficiency, and levels < 20 ng/mL as deficiency. In-hospital and 1-year outcomes were evaluated according to 25 (OH)D level quartiles, using the lowest quartile as a reference. Ninety-three (11%) patients had normal 25 (OH)D levels, whereas 155 (19%) and 566 (70%) had vitamin D insufficiency and deficiency, respectively. The median 25 (OH)D level was similar in ST-elevation myocardial infarction (STEMI) and non-ST-elevation myocardial infarction (NSTEMI) patients (14.1 [IQR 9.0–21.9] ng/mL and 14.05 [IQR 9.1–22.05] ng/mL, respectively; P = .88). The lowest quartile of 25 (OH)D was associated with a higher risk for several in-hospital complications, including mortality. At a median follow-up of 366 (IQR 364–379) days, the lowest quartile of 25 (OH)D, after adjustment for the main confounding factors, remained significantly associated to 1-year mortality (P < .01). Similar results were obtained when STEMI and NSTEMI patients were considered separately. In ACS patients, severe vitamin D deficiency is independently associated with poor in-hospital and 1-year outcomes. Whether low vitamin D levels represent a risk marker or a risk factor in ACS remains to be elucidated.
- 1 May 2015
- Published by Wolters Kluwer Health in Medicine
- Vol. 94 (19) , e857-8
Open AccessVitamin D Plasma Levels and In-Hospital and 1-Year Outcomes in Acute Coronary Syndromes
Deficiency in 25-hydroxyvitamin D (25[OH]D), the main circulating form of vitamin D in blood, could be involved in the pathogenesis of acute coronary syndromes (ACS). To date, however, the possible prognostic relevance of 25 (OH)D deficiency in ACS patients remains poorly defined. The purpose of this prospective study was to assess the association between 25 (OH)D levels, at hospital admission, with in-hospital and 1-year morbidity and mortality in an unselected cohort of ACS patients. We measured 25 (OH)D in 814 ACS patients at hospital presentation. Vitamin D serum levels >30 ng/mL were considered as normal; levels between 29 and 21 ng/mL were classified as insufficiency, and levels < 20 ng/mL as deficiency. In-hospital and 1-year outcomes were evaluated according to 25 (OH)D level quartiles, using the lowest quartile as a reference. Ninety-three (11%) patients had normal 25 (OH)D levels, whereas 155 (19%) and 566 (70%) had vitamin D insufficiency and deficiency, respectively. The median 25 (OH)D level was similar in ST-elevation myocardial infarction (STEMI) and non-ST-elevation myocardial infarction (NSTEMI) patients (14.1 [IQR 9.0–21.9] ng/mL and 14.05 [IQR 9.1–22.05] ng/mL, respectively; P = .88). The lowest quartile of 25 (OH)D was associated with a higher risk for several in-hospital complications, including mortality. At a median follow-up of 366 (IQR 364–379) days, the lowest quartile of 25 (OH)D, after adjustment for the main confounding factors, remained significantly associated to 1-year mortality (P < .01). Similar results were obtained when STEMI and NSTEMI patients were considered separately. In ACS patients, severe vitamin D deficiency is independently associated with poor in-hospital and 1-year outcomes. Whether low vitamin D levels represent a risk marker or a risk factor in ACS remains to be elucidated.
- 1 March 2015
- Published by Elsevier in American Heart Journal
- Vol. 169 (3) , 363-370
Prognostic significance of serum creatinine and its change patterns in patients with acute coronary syndromes
- 1 March 2015
- Published by Elsevier in American Heart Journal
- Vol. 169 (3) , 363-370
Prognostic significance of serum creatinine and its change patterns in patients with acute coronary syndromes
- 19 April 2014
- Published by Hindawi Limited in Journal of Cardiac Surgery
- Vol. 29 (6) , 795-796
Cavo‐Atrial Metastases from Cutaneous Melanoma
- 19 April 2014
- Published by Hindawi Limited in Journal of Cardiac Surgery
- Vol. 29 (6) , 795-796
Cavo‐Atrial Metastases from Cutaneous Melanoma